Trial Profile
Phase I/II study of docetaxel (taxotere) and estramustine combination chemotherapy in patients with prostate cancer
Status:
Active, no longer recruiting
Phase of Trial:
Phase I/II
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Docetaxel (Primary) ; Estramustine (Primary)
- Indications Prostate cancer
- Focus Adverse reactions; Therapeutic Use
- 03 Oct 2005 New trial record.